A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Clinical trial NCT01991184 · COMPLETED

Trial details

NCT number: NCT01991184
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma

Start date: 2013-12-16
Primary completion: 2022-03-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.